Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis (MS) is a disease with unknown cause characterized by inflammation and demyelination in the central nervous system. Although an autoimmune pathogenesis has been suggested, there are no conclusive data on the number of T cells autoreactive with myelin antigens in MS compared to controls. We showed that T lymphocytes secreting interferon-gamma in response to possible target autoantigens are severalfold more common among PBL mononuclear cells in patients with MS than in patients with aseptic meningitis and tension headache. On average T cells reactive with myelin basic protein (MBP), two different MBP peptides, or with proteolipid protein amounted to 2.7-5.2/10(5) PBL from MS patients. MBP-reactive T cells were still more frequent among mononuclear cells isolated from the cerebrospinal fluid (CSF; 185/10(5) CSF cells). We concluded that T cells reactive with myelin autoantigens are strongly increased in MS. This approach to detect them could allow definition of immunodominant T cell epitopes in individual MS patients, and thereby enable further development towards specific immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
The Basis for the Immunoregulatory Role of Macrophages and Other Accessory Cells
Unanue, E. R., & Allen, P. M. (1987) · Science · doi:10.1126/science.2437650 · Cited by 1,021
Deibler, G. E., Martenson, R. E., & Kies, M. W. (1972) · Preparative Biochemistry · doi:10.1080/00327487208061467 · Cited by 935
Ben‐Nun, A., Wekerle, H., & Cohen, I. R. (1981) · European Journal of Immunology · doi:10.1002/eji.1830110307 · Cited by 916
Cellular immune reactivity within the CNS
Wekerle, H., Linington, C., Lassmann, H., & Meyermann, R. (1986) · Trends in Neurosciences · doi:10.1016/0166-2236(86)90077-9 · Cited by 768
Panitch, H. S., Hirsch, R. L., Schindler, J., & Johnson, K. P. (1987) · Neurology · doi:10.1212/wnl.37.7.1097 · Cited by 751
Buus, S., Sette, A., Colon, S. M., Miles, C., & Grey, H. M. (1987) · Science · doi:10.1126/science.2435001 · Cited by 674
Vandenbark, A. A., Hashim, G., & Offner, H. (1989) · Nature · doi:10.1038/341541a0 · Cited by 578
Czerkinsky, C., Andersson, G., Ekre, H.-P., Nilsson, L.-Å., Klareskog, L., & Ouchterlony, Ö. (1988) · Journal of Immunological Methods · doi:10.1016/0022-1759(88)90079-8 · Cited by 495
Self-citation
Cited by
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
“Whereas tissue culture–based techniques have shown frequencies of about 1 MBP-specific cell per 106−107 PBMC (71, 105), approximately 1–2 orders of magnitude higher numbers were observed with enzyme-linked immunospot (ELISPOT) assays, which detect IFN-γ -secreting cells (72).”
Interleukin-18 Regulates Both Th1 and Th2 Responses
Nakanishi, K., Yoshimoto, T., Tsutsui, H., & Okamura, H. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.423 · Cited by 1,315
NAKANISHI, K., YOSHIMOTO, T., TSUTSUI, H., & OKAMURA, H. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00015-0 · Cited by 662
Determinant spreading and the dynamics of the autoimmune T-cell repertoire
Lehmann, P. V., Sercarz, E. E., Forsthuber, T., Dayan, C. M., & Gammon, G. (1993) · Immunology Today · doi:10.1016/0167-5699(93)90163-f · Cited by 461
Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
Martin, R., McFarland, H. F., & Boggs, J. M. (1995) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408369509084683 · Cited by 376
Angeles Muñoz-Fernández, M., & Fresno, M. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00045-8 · Cited by 367
Inflammation in central nervous system injury
Allan, S. M., & Rothwell, N. J. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1358 · Cited by 345
Effector T Cells in Multiple Sclerosis
Kaskow, B. J., & Baecher-Allan, C. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029025 · Cited by 314
T-bet is essential for encephalitogenicity of both Th1 and Th17 cells
Yang, Y., Weiner, J., Liu, Y., Smith, A. J., Huss, D. J., Winger, R., Peng, H., Cravens, P. D., Racke, M. K., & Lovett-Racke, A. E. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082584 · Cited by 282
Sun, J., Olsson, T., Wang, W., Xiao, B., Kostulas, V., Fredrikson, S., Ekre, H., & Link, H. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210620 · Cited by 257
Self-citationInflammation and therapeutic vaccination in CNS diseases
Weiner, H. L., & Selkoe, D. J. (2002) · Nature · doi:10.1038/nature01325 · Cited by 255
Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization
Sewell, D. (2003) · International Immunology · doi:10.1093/intimm/dxg012 · Cited by 254
Inflammation-related plasma and CSF biomarkers for multiple sclerosis
Huang, J., Khademi, M., Fugger, L., Lindhe, Ö., Novakova, L., Axelsson, M., Malmeström, C., Constantinescu, C., Lycke, J., Piehl, F., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912839117 · Cited by 194
“Multiple sclerosis is believed to be driven by systemic immune activation of autoimmunity against CNS components (4, 5), where encephalitogenic cells accumulate in the target organ (6, 7).”
BackgroundSelf-citationMicro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity
Guerau-de-Arellano, M., Smith, K. M., Godlewski, J., Liu, Y., Winger, R., Lawler, S. E., Whitacre, C. C., Racke, M. K., & Lovett-Racke, A. E. (2011) · Brain · doi:10.1093/brain/awr262 · Cited by 188
Beyond the gut: decoding the gut–immune–brain axis in health and disease
Park, J. C., Chang, L., Kwon, H.-K., & Im, S.-H. (2025) · Cellular & Molecular Immunology · doi:10.1038/s41423-025-01333-3 · Cited by 149
“During multiple sclerosis (MS), autoreactive CD4 ⁺ T cells recognize myelin antigens, leading to CNS in fl ammation and demyelination [162].”
Cellular architecture of evolving neuroinflammatory lesions and multiple sclerosis pathology
Kukanja, P., Langseth, C. M., Rubio Rodríguez-Kirby, L. A., Agirre, E., Zheng, C., Raman, A., Yokota, C., Avenel, C., Tiklová, K., Guerreiro-Cacais, A. O., et al. (2024) · Cell · doi:10.1016/j.cell.2024.02.030 · Cited by 124
Self-citationInterferon γ- and interleukin-4-secreting cells in multiple sclerosis
Lu, C.-Z., Jensen, M. A., & Arnason, B. G. W. (1993) · Journal of Neuroimmunology · doi:10.1016/0165-5728(93)90241-p · Cited by 77
“…supernate than control PBMC (Hirsch et al., 1985); (4) T cells that spontaneously secrete IFNy are enriched in the cerebrospinal fluid (CSF) in MS (Olsson et al., 1990); (5) interferonbeta 1/3 which inhibits IFNy production by PBMC from MS patients (Panitch et al., 1987a; Noronha et al., 1992)…”
BackgroundStatistical positivity criteria for the analysis of ELISpot assay data in HIV-1 vaccine trials
Moodie, Z., Huang, Y., Gu, L., Hural, J., & Self, S. G. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.07.015 · Cited by 68
Metadata
- Authors
- Olsson, T., Zhi, W. W., Höjeberg, B., Kostulas, V, Jiang, Y. P., Anderson, G., Ekre, H. P., & Link, H.
- Venue
- Journal of Clinical Investigation
- Published
- 1990-09-01
- Volume
- 86
- Issue
- 3
- Pages
- 981-985
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2014384707
- Cited by
- 368
- References
- 33
- FWCI
- 18.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.